Want to see IN:AJOONI full AI Analyst Report?
AJOONI Stock Chart & Stats
₹5.13
₹0.07(0.90%)
At close: 4:00 PM EST
₹5.13
₹0.07(0.90%)
Day’s Range― - ―
52-Week Range₹3.40 - ₹5.94
Previous CloseN/A
Volume422.93K
Average Volume (3M)354.25K
Market Cap
₹713.09M
Enterprise Value₹829.69M
Total Cash (Recent Filing)₹4.19M
Total Debt (Recent Filing)₹177.63M
Price to Earnings (P/E)17.1
Beta1.19
Next Earnings
Jul 30, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.25
Shares Outstanding172,243,590
10 Day Avg. Volume263,831
30 Day Avg. Volume354,249
Financial Highlights & Ratios
PEG Ratio-0.85
Price to Book (P/B)2.02
Price to Sales (P/S)1.01
P/FCF Ratio-7.94
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Strong Revenue GrowthMaterial top-line acceleration (≈44% YoY in FY2026) indicates improving scale and rising product adoption in core animal nutrition markets. Durable revenue momentum supports investment capacity, distribution expansion and long-term market share gains if cash conversion improves.
Conservative LeverageA modest debt-to-equity ratio (~0.19) implies financial flexibility and lower immediate solvency risk, enabling the company to fund working capital or targeted growth spending without heavy interest burdens. This conservative starting leverage supports resilience over the medium term.
Essential, Recurring Business ModelOperating in animal health and feed supplements creates recurring demand tied to livestock and poultry cycles and broad distribution to farmers/distributors. This essential goods positioning tends to produce steady baseline demand and supports long-term revenue durability versus discretionary sectors.
Bears Say
Persistent Negative Cash FlowSustained negative operating and free cash flow across multiple years shows reported profits are not converting to cash. This structural cash-conversion gap raises ongoing funding and execution risk, increasing reliance on external financing or equity issuance to support operations and growth.
Thin, Volatile MarginsLow and declining margins limit the company’s capacity to self-fund investment, absorb raw-material or pricing shocks, and generate returns on equity. Margin pressure constrains free cash flow recovery and heightens sensitivity to cost inflation or competitive pricing dynamics over the medium term.
Rising Debt Trend To MonitorAlthough absolute leverage remains modest, a material increase in debt in FY2026 signals a worsening leverage trajectory. Coupled with persistent cash burn, rising debt could strain liquidity, raise financing costs, and reduce strategic flexibility if cash conversion does not improve.
Ajooni Biotech Limited News
AJOONI FAQ
What was Ajooni Biotech Limited’s price range in the past 12 months?
Ajooni Biotech Limited lowest stock price was ₹3.40 and its highest was ₹5.94 in the past 12 months.
What is Ajooni Biotech Limited’s market cap?
Ajooni Biotech Limited’s market cap is ₹713.09M.
When is Ajooni Biotech Limited’s upcoming earnings report date?
Ajooni Biotech Limited’s upcoming earnings report date is Jul 30, 2026 which is in 8 days.
How were Ajooni Biotech Limited’s earnings last quarter?
Ajooni Biotech Limited released its earnings results on May 28, 2026. The company reported ₹0.055 earnings per share for the quarter, beating the consensus estimate of N/A by ₹0.055.
Is Ajooni Biotech Limited overvalued?
According to Wall Street analysts Ajooni Biotech Limited’s price is currently Overvalued.
Does Ajooni Biotech Limited pay dividends?
Ajooni Biotech Limited does not currently pay dividends.
What is Ajooni Biotech Limited’s EPS estimate?
Ajooni Biotech Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Ajooni Biotech Limited have?
Ajooni Biotech Limited has 172,243,590 shares outstanding.
What happened to Ajooni Biotech Limited’s price movement after its last earnings report?
Ajooni Biotech Limited reported an EPS of ₹0.055 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Ajooni Biotech Limited?
Currently, no hedge funds are holding shares in IN:AJOONI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Ajooni Biotech Limited
Founded in 2010, Ajooni Biotech Limited is an Indian enterprise primarily engaged in the production and distribution of animal nutrition products. Headquartered in Mohali, India, the company's offerings encompass specialized cattle feeds and various dietary supplements for livestock.
Technical Analysis
Avanti Feeds Limited
―
M K Proteins Limited
―
Mukka Proteins Limited
―
Parag Milk Foods Ltd.
―
SKM Egg Products Export (India) Ltd.
―